EL PASO, TX, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- SponsorBase has launched what the company describes ...
Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback